CYTOSORBENTS CORP's ticker is CTSO and the CUSIP is 23283X206. A total of 98 filers reported holding CYTOSORBENTS CORP in Q1 2021. The put-call ratio across all filers is 2.28 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $53,000 | -8.6% | 24,367 | +33.3% | 0.00% | -20.0% |
| Q1 2022 | $58,000 | -27.5% | 18,275 | -4.4% | 0.01% | -28.6% |
| Q4 2021 | $80,000 | -55.8% | 19,114 | -14.3% | 0.01% | -68.2% |
| Q3 2021 | $181,000 | +19.9% | 22,312 | +11.4% | 0.02% | -4.3% |
| Q2 2021 | $151,000 | +3.4% | 20,031 | +19.2% | 0.02% | -28.1% |
| Q1 2021 | $146,000 | – | 16,800 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Skylands Capital, LLC | 815,869 | $3,141,000 | 0.46% |
| Sargent Investment Group, LLC | 499,010 | $1,921,000 | 0.36% |
| Anson Funds Management LP | 74,440 | $287,000 | 0.33% |
| One68 Global Capital, LLC | 39,241 | $151,000 | 0.33% |
| Granahan Investment Management | 678,618 | $2,613,000 | 0.12% |
| Winning Points Advisors, LLC | 30,000 | $115,000 | 0.07% |
| Avenir Corp | 150,600 | $580,000 | 0.06% |
| HighMark Wealth Management LLC | 10,000 | $38,000 | 0.04% |
| Wealthcare Advisory Partners LLC | 62,279 | $240,000 | 0.03% |
| GSA CAPITAL PARTNERS LLP | 64,970 | $250,000 | 0.03% |